Hiroshi Fukuhara Selected Research

Stress Urinary Incontinence

1/2020

Effects on Depression and Anxiety After Mid-Urethral Sling Surgery for Female Stress Urinary Incontinence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Fukuhara Research Topics

Disease

40	Neoplasms (Cancer) 08/2023 - 07/2002
31	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 09/2005
16	Carcinoma (Carcinomatosis) 12/2023 - 03/2012
13	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2007
11	Urinary Bladder Neoplasms (Bladder Cancer) 08/2023 - 01/2015
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2014
5	Overactive Urinary Bladder (Overactive Bladder) 01/2023 - 04/2015
4	Melanoma (Melanoma, Malignant) 03/2023 - 10/2016
4	Dehydration (Water Stress) 01/2023 - 12/2002
4	Adenocarcinoma 01/2021 - 11/2005
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2019 - 09/2015
3	Margins of Excision 01/2024 - 01/2012
3	Lymphatic Metastasis 09/2023 - 09/2012
3	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2022 - 01/2020
3	Stomach Neoplasms (Stomach Cancer) 11/2021 - 02/2021
2	Sarcopenia 11/2023 - 06/2016
2	Hydronephrosis 01/2022 - 10/2017
2	Sepsis (Septicemia) 03/2020 - 03/2014
2	Hypotension (Low Blood Pressure) 07/2019 - 01/2017
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2018 - 05/2017
2	Infections 12/2016 - 07/2013
2	Lung Neoplasms (Lung Cancer) 09/2002 - 07/2002
1	Pelvic Neoplasms 08/2023
1	Hypertensive Nephropathy 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Hyperglycemia 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Nephrosclerosis 01/2023

Drug/Important Bio-Agent (IBA)

8	AndrogensIBA 05/2018 - 09/2005
6	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 09/2013
5	pembrolizumabIBA 12/2023 - 01/2021
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 07/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
5	Docetaxel (Taxotere)FDA Link 01/2021 - 12/2011
4	mirabegronIBA 01/2023 - 10/2015
4	AlbuminsIBA 01/2021 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 08/2023 - 09/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 12/2002
3	Hormones (Hormone)IBA 11/2022 - 09/2005
3	Tolvaptan FDA Link 02/2022 - 01/2020
3	talimogene laherparepvecIBA 03/2019 - 10/2016
3	C-Reactive ProteinIBA 09/2017 - 05/2011
2	Immune Checkpoint InhibitorsIBA 12/2023 - 10/2016
2	Indicators and Reagents (Reagents)IBA 11/2023 - 09/2011
2	Ifosfamide FDA LinkGeneric 09/2023 - 03/2015
2	Interleukin-12 (IL 12)IBA 03/2023 - 01/2006
2	ReninIBA 01/2023 - 10/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 12/2011
2	enzalutamideIBA 03/2022 - 02/2022
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021 - 06/2021
2	CytokinesIBA 02/2021 - 01/2018
2	GlobulinsIBA 01/2021 - 08/2020
2	naftopidilIBA 01/2020 - 12/2013
2	Muscarinic AntagonistsIBA 01/2019 - 05/2017
2	silodosin FDA Link 01/2018 - 05/2017
2	imidafenacinIBA 05/2017 - 04/2015
2	Alkaline PhosphataseIBA 01/2017 - 05/2011
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 02/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2016 - 11/2014
2	Tyrosine Kinase InhibitorsIBA 11/2014 - 01/2014
2	Interleukin-2 (IL2)IBA 07/2007 - 06/2006
2	CS 834IBA 12/2003 - 12/2002
2	1 beta-methylcarbapenemIBA 12/2003 - 12/2002
2	Immunoglobulins (Immunoglobulin)IBA 09/2002 - 07/2002
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 09/2002 - 07/2002
1	PlatinumIBA 12/2023
1	enfortumab vedotinIBA 12/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2023
1	Etoposide (VP 16)FDA LinkGeneric 09/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2023
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 08/2023
1	Therapeutic UsesIBA 01/2023
1	Ion Channels (Ion Channel)IBA 01/2023
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 01/2023
1	Proton Pump InhibitorsIBA 01/2023
1	SaltsIBA 01/2023
1	esaxerenoneIBA 01/2023
1	Gemcitabine FDA Link 11/2022
1	Carboplatin (JM8)FDA LinkGeneric 11/2022

Therapy/Procedure

24	Therapeutics 01/2024 - 09/2005
23	Prostatectomy (Retropubic Prostatectomy) 01/2024 - 01/2014
11	Drug Therapy (Chemotherapy) 12/2023 - 12/2011
10	Oncolytic Virotherapy 11/2021 - 11/2005
8	Radiotherapy 01/2024 - 09/2014
7	Cystectomy 01/2022 - 01/2015
4	Immunotherapy 01/2023 - 07/2007
4	Castration 03/2022 - 03/2015
4	Nephroureterectomy 01/2022 - 01/2015
3	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 01/2012
3	Transurethral Resection of Bladder 01/2022 - 01/2021
3	Nephrectomy 01/2017 - 06/2012
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 11/2019
2	Metastasectomy 09/2023 - 09/2017
2	Brachytherapy 11/2022 - 09/2020
2	Intravesical Administration 01/2020 - 11/2016
2	Neoadjuvant Therapy 02/2018 - 04/2015
2	Adjuvant Chemotherapy 10/2017 - 04/2015
2	Orchiectomy (Orchidectomy) 11/2016 - 01/2012